B
아이빔테크놀로지
460470KOSDAQ사진장비 및 광학기기 제조업57.3 / 100
Reference Date: 2026-06-10
Financial Score22.0 / 40
News Sentiment21.3 / 25
Momentum2.0 / 20
Disclosure12.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Plunged 23.3% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
AIBeam Technology develops and provides high-resolution in vivo microscopes, imaging accessories, and CRO services, enabling cellular-level analysis of internal organs and tissues in live animals. The company also offers AI-based medical devices for cancer diagnosis and precise tissue analysis.
Number of Employees
37people
Average Salary
39.6M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 17.864.0Point
PBR
1.71Industry Average 2.164.0Point
In line with industry avg
ROE
-12.91Industry Average -11.913.5Point
In line with industry avg
Debt Ratio
5.57Industry Average 18.096.5Point
Half of industry avg (excellent)
Trend 2024~20254.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲22.8% (1-year basis)
Operating Profit Growth Rate
1.0 / 3
Avg ▲3.6% (1-year basis)
ROE Trend
0.0 / 4
Avg ROE -15.5% (improving, 2yr)
Detailed News Sentiment
2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85
- Positive아이빔테크놀로지, 이탈리아 업체와 6억 규모 생체현미경 공급계약
아이빔테크놀로지는 이탈리아 업체와의 대규모 생체현미경 공급계약 체결로 매출 증대 기대.
- Positive"조직 추출 15분 만에 암 판독"…AI 생체현미경 상용화 눈앞
아이빔테크놀로지의 AI 기반 조직분석 기술 상용화 임박으로 암 진단 속도 향상 기대.
Detailed Momentum
52-week position1.0Point
Near 52w low (19%, downtrend)
Current 3,130Won52-week high 4,74552-week low 2,740
1-month return0.0Point
1m -23.28% (strong drop)
Volume trend1.0Point
Volume dry-up
Detailed Disclosure
2 totalPositive 1Neutral 1Negative 0
- Positive단일판매ㆍ공급계약체결2026-05-26
- Neutral분기보고서 (2026.03)2026-05-14